Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease-Reference-Cited by-同舟云学术

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease

Published:2021-12 Issue: Volume: Page:
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Shah Niketa C.,Bhoopatiraju Sweta,Abraham Allistair,Anderson Eric^ORCID,Andreansky Martin,Bhatia Monica,Chaudhury Sonali,Cuvelier Geoff D.E.,Godder Kamar,Grimley Michael^ORCID,Hale Gregory,Kamani Naynesh,Jacobsohn David,Ngwube Alexander,Gilman Andrew L.,Skiles Jodi,Yu Lolie C.,Shenoy Shalini

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference39 articles.

1. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia;Hartmann;N Engl J Med,1997

2. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation;Dekker;J Clin Oncol,2006

3. The effect of granulocyte colony-stimulating factor use on hospital length of stay after allogeneic hematopoietic cell transplantation: a retrospective multicenter cohort study;George;Biol Blood Marrow Transplant,2020

4. Sickle red cell-endothelium interactions;Kaul;Microcirculation,2009

5. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease;Abboud;Br J Haematol,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haematopoietic stem cell mobilisation followed by high‐dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma;British Journal of Haematology;2023-07-24

2. Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease;Journal of Clinical Medicine;2022-07-03